Use of electronic cigarettes in the perioperative period: A mixed-method study exploring perceptions of cardiothoracic patients in Australia
More details
Hide details
Department of Psychology, Macquarie University, Sydney, Australia
Australian Institute of Health Innovation, Macquarie University, Sydney, Australia
Austin Clinical School of Nursing, La Trobe University, Melbourne, Australia
Discipline of Physiotherapy, University of Sydney, Sydney, Australia
Publish date: 2018-11-12
Tob. Induc. Dis. 2018;16(November):53
Electronic cigarettes (e-cigarettes) may reduce tobacco use and achieve tobacco abstinence in the perioperative period of cardiothoracic surgery for patients who smoke. However, research on patients’ views on the role of e-cigarettes as a smoking cessation tool is lacking. This mixed-methods study explored perceptions on the use of e-cigarettes among current smokers and exsmokers awaiting cardiothoracic surgery in Australia.

A cross-sectional study and semi-structured interviews were conducted with 62 patients who were diagnosed with coronary artery disease or lung cancer and were scheduled for elective cardiothoracic surgery at six metropolitan hospitals in Sydney. Data were collected on demographic characteristics, smoking history, surgical risk index, self-efficacy, interest in, perceived benefits of, and barriers to using e-cigarettes in the perioperative period.

Current smokers reported significantly higher interest in the use of e-cigarettes (p=0.008), and perceived fewer barriers (p=0.048) and more health benefits (p=0.079), compared to ex-smokers. Current smokers considered e-cigarettes to be either a safer alternative to tobacco or a novel method for quitting. Recent ex-smokers, defined as those who quit 2–8 weeks, were a distinct group with high nicotine dependency, a long history of smoking, and multiple failed quit attempts. Compared to longer-term ex-smokers (8–52 weeks quit), recent ex-smokers were more interested in e-cigarettes (p=0.029) and considered e-cigarettes a useful aid to prevent relapse in the lead up to surgery and to manage their nicotine cravings.

E-cigarettes may be considered a short-term novel aid and a bridge to evidence-based methods to reduce harm from continued tobacco use for some patients awaiting cardiothoracic surgery for coronary artery disease or lung cancer. This study presents reasons why patients awaiting cardiothoracic surgery may enquire about or use e-cigarettes, which will help clinicians identify those who need more consistent, sustained cessation support.

Nia A. Luxton   
Department of Psychology, Macquarie University, Balaclava Road, North Ryde, NSW 2109, Sydney, Australia
1. Glasser AM, Collins L, Pearson JL, et al. Overview of Electronic Nicotine Delivery Systems: A Systematic Review. Am J Prev Med. 2017;52(2):e33-e66. doi:10.1016/j.amepre.2016.10.036
2. National Academies of Sciences E, and Medicine. Public health consequences of e-cigarettes. Published January, 2018. Accessed August, 2018.
3. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PloS One. 2015;10(3). doi:10.1371/journal.pone.0122544
4. Hartmann-Boyce J, Begh R, Aveyard P. Electronic cigarettes for smoking cessation. BMJ. 2018;360:j5543. doi:10.1136/bmj.j5543
5. van Domburg RT, Meeter K, van Berkel DF, Veldkamp RF, van Herwerden LA, Bogers AJ. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol. 2000;36(3):878-883. doi:10.1016/s0735-1097(00)00810-x
6. Warner DO. Helping surgical patients quit smoking: why, when, and how. Anesth Analg. 2005;101(2):481-487. doi:10.1213/01.ane.0000159152.31129.84
7. Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132(2):401-410. doi:10.1002/ijc.27617
8. Kadimpati S, Nolan M, Warner DO. Attitudes, beliefs, and practices regarding electronic nicotine delivery systems in patients scheduled for elective surgery. Mayo Clin Proc. 2015;90(1):71-76. doi:10.1016/j.mayocp.2014.11.005
9. Nolan M, Leischow S, Croghan I, et al. Feasibility of Electronic Nicotine Delivery Systems in Surgical Patients. Nicotine Tob Res. 2016;18(8):1757-1762. doi:10.1093/ntr/ntw003
10. Parliament of Australia. Inquiry into the Use and Marketing of Electronic Cigarettes and Personal Vaporisers in Australia. Published March, 2018. Accessed August 6, 2018.
11. Rigotti NA, Chang Y, Tindle HA, et al. Association of e-cigarette use with smoking cessation among smokers who plan to quit after a hospitalization. Ann Intern Med. 2018;168(9):613-620. doi:10.7326/M17-2048
12. Notley C, Ward E, Dawkins L, Holland R. The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention. Harm Reduct J. 2018;15(1):31.doi:10.1186/s12954-018-0237-7
13. Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014;120(22):3527-3535. doi:10.1002/cncr.28811
14. Busch AM, Leavens EL, Wagener TL, Buckley ML, Tooley EM. Prevalence, reasons for use, and risk perception of electronic cigarettes among post-acute coronary syndrome smokers. J Cardiopulm Rehabil Prev. 2016;36(5):352-357. doi:10.1097/HCR.0000000000000179
15. Kalkhoran S, Kruse GR, Rigotti NA, Rabin J, Ostroff JS, Park ER. Electronic cigarette use patterns and reasons for use among smokers recently diagnosed with cancer. Cancer Med. 2018;7. doi:10.1002/cam4.1585
16. Kruse GR, Kalkhoran S, Rigotti NA. Use of Electronic Cigarettes Among U.S. Adults With Medical Comorbidities. Am J Prev Med. 2017;52(6):798-804. doi:10.1016/j.amepre.2016.12.004
17. Correa JB, Brandon KO, Meltzer LR, et al. Electronic cigarette use among patients with cancer: Reasons for use, beliefs, and patient‐provider communication. Psychooncology. 2018;27(7):1757-1764. doi:10.1002/pon.4721
18. Australian Institute of Health and Welfare. Australia’s health 2018. Cat. no. AUS 221. Canberra: AIHW. Published June, 2018. Accessed August 26, 2018.
19. Australian Institute of Health and Welfare. Cancer in Australia 2017. Cat. no. CAN 100. Canberra: AIHW. Published February, 2017. Accessed August 26, 2018.
20. Australian Institute of Health and Welfare. Cardiovascular disease snapshot. Cat. no. CVD 83. Canberra: AIHW. Published July, 2018. Accessed August 26, 2018.
21. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156-170. doi:10.1093/her/18.2.156
22. Shi Y, Warner DO. Surgery as a teachable moment for smoking cessation. Anesthesiology. 2010;112(1):102-107. doi:10.1097/ALN.0b013e3181c61cf9
23. Luxton NA, MacKenzie R, Shih P. Smoking cessation care in cardiothoracic surgery: A qualitative study exploring the views of Australian clinicians. Heart Lung Circ. 2018. doi:10.1016/j.hlc.2018.04.293
24. Rojewski AM, Baldassarri S, Cooperman NA, et al. Exploring Issues of Comorbid Conditions in People Who Smoke. Nicotine Tob Res. 2016;18(8):1684-1696. doi:10.1093/ntr/ntw016
25. Cancer Institute NSW. NSW Smoking & Health Survey 2015. Published February, 2018. Accessed August 26, 2018.
26. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2016: detailed findings. Drug Statistics Series no. 31. Cat. No. PHE 214. Canberra: AIHW. Published January, 2018. Accessed August 26, 2018.
27. Thomas D, Abramson MJ, Bonevski B, et al. Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers. BMJ Open. 2015;5(4). doi:10.1136/bmjopen-2014-006959
28. Curry L, Nunez-Smith M. Mixed methods in health sciences research: A practical primer. Vol 1. Sage Publications; 2014.
29. Bureau of Health Information. Healthcare Quarterly. Performance Profiles. Elective Surgery. January to March 2018. Published May, 2018. Accessed August 6, 2018.
30. Morales NA, Romano MA, Cummings KM, et al. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control. 2013;24(6):1223-1230. doi:10.1007/s10552-013-0202-4
31. Attebring MF, Herlitz J, Berndt AK, Karlsson T, Hjalmarson A. Are patients truthful about their smoking habits? A validation of self-report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease. J Intern Med. 2001;249(2):145-151. doi:10.1046/j.1365-2796.2001.00770.x
32. Glantz L. Should smokers be refused surgery? BMJ. 2007;334(7583):21. doi:10.1136/bmj.39059.532095.68
33. Australian Institute of Health and Welfare. Elective surgery waiting times 2016-17: Australian hospital statistics. AIHW cat. no. HSE 197. Published December, 2018. Accessed August 26, 2018.
34. NSW Health. Managing Nicotine Dependence: A Guide for NSW Health Staff. Published January, 2015. Accessed August 26, 2018.
35. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström K. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x
36. Yu C, Shi Y, Kadimpati S, et al. Perioperative smoking behavior of Chinese surgical patients. Anesth Analg. 2013;116(6):1238-1246. doi:10.1213/ANE.0b013e31828e5cf0
37. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-1288. doi:10.1177/1049732305276687
38. Creswell J, Plano Clark V. Designing and conducting mixed methods research. California: SAGE Publications Inc.; 2011.
39. NVivo qualitative data analysis [computer program]. Version 11, 2017.
40. Mays N, Pope C. Assessing quality in qualitative research. BMJ. 2000;320(7226):50-52.
41. Baker BT, Collins LM, Robin M, et al. Enhancing the effectiveness of smoking treatment research: conceptual bases and progress. Addiction. 2016;111(1):107-116. doi:10.1111/add.13154
42. Borland R, Partos TR, Yong HH, Cummings KM, Hyland A. How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction. 2012;107(3):673-682. doi:10.1111/j.1360-0443.2011.03685.x
43. Twyman L, Bonevski B, Paul C, Bryant J, Gartner C, Guillaumier A. Electronic Cigarettes: Awareness, Recent Use, and Attitudes Within a Sample of Socioeconomically Disadvantaged Australian Smokers. Nicotine Tob Res. 2016;18(5):670-677. doi:10.1093/ntr/ntv183
44. Department of Health. Therapeutic Goods Administration. Published January, 2018. Accessed August 6, 2018.
45. The Royal Australian College of General Practitioners. Supporting smoking cessation: a guide for health professionals. Published December, 2011. Updated July, 2014. Accessed August 26, 2018.
46. Thomas D, Abramson MJ, Bonevski B, et al. Integrating smoking cessation into routine care in hospitals-a randomized controlled trial. Addiction. 2016;111(4):714-723. doi:10.1111/add.13239
47. Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control. 2010;19(5):410-416. doi:10.1136/tc.2009.033175
48. Nolan MB, Warner DO. Perioperative tobacco use treatments: putting them into practice. BMJ. 2017;358:j3340. doi:10.1136/bmj.j3340
49. Parliament of Australia. Report on the Inquiry into the Use and Marketing of Electronic Cigarettes and Personal Vaporisers in Australia. Published, 2018. Accessed October 11, 2018.